BEMFLUGO
Live / Registered — Registered (as of 14 Oct 2025)
What this means for you
Registered since 14 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98891830
- Registration number
- 7981878
- Mark type
- Stylized text
- Filed
- 09 Dec 2024
- Published for opposition
- 26 Aug 2025
- Registered
- 14 Oct 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 14 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 29 May 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 29 May 2025 — LETTER OF SUSPENSION E-MAILED
- 29 May 2025 — SUSPENSION LETTER WRITTEN
- 29 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 29 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 May 2025 — EXAMINERS AMENDMENT E-MAILED